Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines. Ann Pharmacother 2005;39:2056–64.Morgan MM, Khan DA, Nathan RA. Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines. Ann Pharmacother 2005; 39(12):2056-64....
PI3K inhibitors have been considered to have great potential in the treatment of inflammation. Current evidence shows that PI3K participates in the pathogenesis of asthma through two main mechanisms. First, PI3K increases the permeability of mouse blood vessels to enhance antigen-induced airway inflammati...
Allergic rhinoconjunctivitis and urticaria are increasing in prevalence in many developed countries. The role of histamine in such conditions is well documented and clinical guidelines recommend non-sedating H 1 -receptor antagonists as first-line treatment choices. Bilastine is a novel non-sedating hi...
Physical urticaria is a different type of hives with non-allergic causes such as extremes in temperature, exercise, excessive pressure or rubbing of the skin, or sun exposure. Chronic urticaria can be very frustrating to deal with and hard to treat. However, you must be patient and carefully ...
Adrenaline is recommended as the initial treatment of choice for ana... KJL Choo,FER Simons,A Sheikh - John Wiley & Sons, Ltd 被引量: 307发表: 2012年 Chronic Urticaria and Angioedema — NEJM Clinical Practice from The New England Journal of Medicine — Chronic Urticaria and Angioedema AP ...
Angioedema in the absence of urticaria can be due to overproduction of bradykinin. It is exceptional that hereditary deficiency in the C1 inhibitor (HAE-C1-INH) has its onset in the elderly. On the other hand, it is more frequent that acquired C1 inhibitor deficiency (AAE-C1-INH) presents ...
Appearance of skin eruption, itching, or urticaria in the days after the first dose was 14.7% (32 of 218) in this highly allergic cohort. Early Reactions After the Second Dose of Vaccine As of February 22, 2021, 218 highly allergic patients also received the second dose of the BNT162b2 ...
Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Mil Med. 2021;usab138. doi:10.1093/milmed/usab138PubMedGoogle Scholar 26. Arroliga ME, Dhanani K, Arroliga AC, et al. Allergic reactions and adverse events associated with administration of mRNA-...
This review provides an overview of the substantial developments that contribute to our knowledge of the pathogenesis of allergic airway diseases, the mechanism of action of AIT, its treatment routes and schedules, the standardization of extracts and use of adjuvantia. Moreover, the main conclusions...
The present invention is directed generally to a TLR8 agonist VTX-378, for use in the treatment or prevention of allergic diseases, including allergic rhinitis.